Prevnar 13, Pneumonia Vaccine, Approved For Kids Ages 6 To 17 (WELLNESS)
Jan 25 (Reuters) - Pfizer Inc on Friday said U.S. regulators had approved wider use of its Prevnar 13 vaccine to prevent